Aller au contenu principal
Profil bibliographique

Fangliang Gan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

15Publications signalées
13Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Analytical Methods in PharmaceuticalsGastrointestinal motility and disordersPharmacogenetics and Drug MetabolismSexual function and dysfunction studiesGastroesophageal reflux and treatments

Les publications récentes

Accès ouvert 2026 article OpenAlex

Pharmacokinetics and Bioequivalence of Tamsulosin Hydrochloride Extended‐Release Capsules in Healthy Chinese Volunteers: A Randomized, Open‐Label, Crossover Study Under Fasting and Fed Conditions

Lijie Du, Xiaolu Wang, Yi Zhang, Jiamin Yang et autres

Tamsulosin hydrochloride is a long-acting, highly selective α1A receptor antagonist, primarily used to treat benign prostatic hyperplasia. It effectively alleviates lower urinary tract symptoms, including dysuria, nocturia, and urgency caused by prostate enlargement. This study aimed to evaluate the pharmacokinetics and bioequivalence …

cn (code pays fourni par la source)

0 citations Clinical Pharmacology in Drug Development
2026 article OpenAlex

Comparative Pharmacokinetics of Two Extended‐Release Tablet Formulations of Upadacitinib: Bioequivalence Assessment

Biao Sun, Li Zhao, Fangliang Gan, Qiong Zhan

Abstract The aim of this study is to evaluate the pharmacokinetic characteristics, bioequivalence, and safety of two brands of upadacitinib (UPA) extended‐release tablets (15 mg) in healthy Chinese subjects under fasting and postprandial conditions. The plasma concentration of UPA was determined by …

cn (code pays fourni par la source)

0 citations Clinical Pharmacology in Drug Development
2026 article OpenAlex

Pharmacokinetic and Bioequivalence Evaluation of Two Lercanidipine Hydrochloride Tablets in Healthy Chinese Volunteers

Biao Sun, Li Zhao, Fangliang Gan, Qiong Zhan

Abstract Lercanidipine hydrochloride is a third‐generation dihydropyridine calcium channel blocker used to treat mild‐to‐moderate hypertension. The aim of this study is to compare the pharmacokinetic characteristics of lercanidipine hydrochloride tablets (10 mg) in healthy Chinese volunteers after oral administration under fasting conditions …

cn (code pays fourni par la source)

0 citations Clinical Pharmacology in Drug Development
2026 article OpenAlex

Pharmacokinetic and Bioequivalence Evaluation of Two Repaglinide Tablets Under Fasting and Fed Conditions in Healthy Chinese Volunteers

Biao Sun, Li Zhao, Fangliang Gan, Qiong Zhan

Abstract Repaglinide, an insulin secretagogue that predominantly lowers postprandial glucose, is approved for patients with type 2 diabetes inadequately controlled by diet, weight loss, and exercise. This study used a single‐center, randomized, open‐label, two‐formulation, single‐dose, four‐period, fully replicated, crossover design to evaluate …

cn (code pays fourni par la source)

0 citations Clinical Pharmacology in Drug Development
2026 article OpenAlex

Pharmacokinetic Characterization and Bioequivalence of Sildenafil Citrate Orally Disintegrating Tablets in Healthy Volunteers

Yi Zhang, Lijie Du, Shirong Liu, Guiying Chen et autres

Abstract This study characterized the pharmacokinetic (PK) profile and evaluated the bioequivalence of sildenafil citrate under fasting conditions in Chinese subjects. A single‐center, randomized, open‐label, single‐dose, two‐sequence, two‐period crossover study was conducted. Thirty‐eight subjects were randomized (1:1) to the TR or RT …

cn (code pays fourni par la source)

0 citations Clinical Pharmacology in Drug Development
Accès ouvert 2026 article OpenAlex

Pharmacokinetics, Bioequivalence, and Safety of Diclofenac Sodium Sustained‐Release Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions

Biao Sun, Li Zhao, Fangliang Gan, Qiong Zhan

Abstract The study aimed to evaluate the pharmacokinetics, bioequivalence, and safety of domestic diclofenac sodium sustained‐release tablets (0.1 g) and a reference formulation in healthy Chinese subjects. Two independent trials (fasting and fed conditions) were conducted with a single‐center, randomized, open‐label, single‐dose, …

cn (code pays fourni par la source)

0 citations Clinical Pharmacology in Drug Development
2025 article OpenAlex

Pharmacokinetics and Bioequivalence of Ilaprazole Enteric‐Coated Tablets in Healthy Chinese Volunteers: A Two‐Sequence, Four‐Period, Fully Replicated Crossover Study

Linlin Du, Yi Zhang, Fangliang Gan, Jiamin Yang et autres

Abstract Ilaprazole enteric‐coated tablets are a novel proton pump inhibitor primarily used for the treatment of gastroesophageal reflux disease, with metabolism not affected by CYP2C19 genetic polymorphism. This study evaluated the pharmacokinetics and bioequivalence of two formulations of ilaprazole enteric‐coated tablets in …

cn (code pays fourni par la source)

0 citations Clinical Pharmacology in Drug Development
2025 article OpenAlex

Pharmacokinetics and bioequivalence of two N‐acetylcysteine tablets in healthy Chinese volunteers under fasting and fed conditions

Xuebo YIN, Rui Xia, Huan Song, Yi Zhang et autres

N-acetylcysteine (NAC) is a derivative of cysteine with potent mucolytic and antioxidant properties. However, the pharmacokinetics of NAC tablets remain unclear in healthy Chinese subjects. This study aimed to assess the pharmacokinetics, bioequivalence, and safety of a domestically manufactured NAC tablet (600 …

cn (code pays fourni par la source)

0 citations Clinical Pharmacology in Drug Development
2025 article OpenAlex

Pharmacokinetics, Bioequivalence, and Safety of Bromocriptine Mesylate Tablets in Healthy Chinese Subjects

Huan Song, Yujun Chen, Lianlian Chen, Xuebo YIN et autres

To investigate the pharmacokinetic characteristics of bromocriptine mesylate tablets in healthy Chinese subjects and to assess their bioequivalence and safety. A randomized, open-label, single-dose, four-period, two-sequence, complete crossover study was conducted. Forty healthy volunteers were enrolled and administered a single oral dose …

cn (code pays fourni par la source)

0 citations Clinical Pharmacology in Drug Development
2025 article OpenAlex

Pharmacokinetics, Bioequivalence, and Safety of Levothyroxine Sodium Tablets in Healthy Chinese Subjects

Juan Jin, Chunrong Huang, Fangliang Gan, Tuo Li et autres

Recently, a local pharmaceutical company produced levothyroxine sodium tablets, an endogenous drug that helps improve water-salt metabolism and reduce myxedema. However, the bioequivalence of these tablets is not well known. The present study aimed to investigate the bioequivalence, pharmacokinetics, and safety of …

cn (code pays fourni par la source)

0 citations Clinical Pharmacology in Drug Development
Accès ouvert 2025 article OpenAlex

A Randomized, Open‐Label, Two‐Sequence, Crossover Trial Evaluating the Bioequivalence, and Pharmacokinetics of Two Sulfamethoxazole/Trimethoprim Tablet Formulations in Healthy Chinese Volunteers Under Fasting Conditions

Peng Hui Xu, Yuan Liu, Hongcheng Li, Yuyan Lei et autres

Abstract The compound sulfamethoxazole (SMZ)/trimethoprim (TMP), a dual‐agent formulation comprising SMZ and TMP, exhibits synergistic bacteriostatic and bactericidal activity by disrupting folate metabolism pathways. This study assessed the bioequivalence (BE) of a generic compound SMZ/TMP tablet versus its innovator counterpart under fasting …

cn (code pays fourni par la source)

0 citations Clinical Pharmacology in Drug Development

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.